News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
248,062 Results
Type
Article (19454)
Company Profile (184)
Press Release (228424)
Section
Business (68923)
Career Advice (261)
Deals (10331)
Drug Delivery (54)
Drug Development (35654)
Employer Resources (36)
FDA (7697)
Job Trends (6700)
News (123428)
Policy (12105)
Tag
Academia (1657)
Alliances (20024)
Alzheimer's disease (596)
Approvals (7686)
Artificial intelligence (99)
Bankruptcy (62)
Best Places to Work (6353)
Biotechnology (140)
Breast cancer (116)
Cancer (814)
Cardiovascular disease (66)
Career advice (229)
CAR-T (58)
Cell therapy (166)
Clinical research (29055)
Collaboration (308)
Compensation (107)
COVID-19 (1118)
C-suite (66)
Data (910)
Diabetes (99)
Diagnostics (2638)
Drug discovery (52)
Earnings (21130)
Events (36839)
Executive appointments (210)
FDA (8084)
Funding (216)
Gene editing (56)
Gene therapy (131)
GLP-1 (345)
Government (1648)
Healthcare (8683)
Infectious disease (1167)
Inflammatory bowel disease (88)
IPO (4947)
Job creations (779)
Job search strategy (210)
Layoffs (128)
Legal (1901)
Lung cancer (110)
Lymphoma (66)
Manufacturing (107)
Medical device (3932)
Medtech (3933)
Mergers & acquisitions (5515)
Metabolic disorders (269)
Neuroscience (767)
NextGen Class of 2024 (2385)
Non-profit (1798)
Northern California (931)
Obesity (165)
Opinion (71)
People (23568)
Phase I (8325)
Phase II (11795)
Phase III (11128)
Pipeline (281)
Postmarket research (1458)
Preclinical (3361)
Radiopharmaceuticals (171)
Rare diseases (156)
Real estate (1734)
Regulatory (9309)
Research institute (1440)
Southern California (757)
Startups (1500)
United States (7697)
Vaccines (252)
Weight loss (103)
Date
Last 7 days (326)
Last 30 days (1254)
Last 365 days (18055)
2024 (18000)
2023 (19356)
2022 (24048)
2021 (24832)
2020 (22437)
2019 (19223)
2018 (14391)
2017 (13507)
2016 (12462)
2015 (13615)
2014 (9543)
2013 (7942)
2012 (8046)
2011 (7945)
2010 (6470)
Location
Africa (260)
Asia (16185)
Australia (2267)
California (2004)
Canada (594)
China (175)
Colorado (76)
Connecticut (110)
Delaware (63)
Europe (36768)
Florida (257)
Georgia (53)
Illinois (186)
Indiana (151)
Japan (68)
Kansas (57)
Maryland (237)
Massachusetts (1728)
Minnesota (71)
New Jersey (658)
New York (519)
North Carolina (419)
Northern California (931)
Ohio (71)
Pennsylvania (409)
South America (325)
Southern California (757)
Texas (207)
Utah (61)
Washington State (208)
248,062 Results for "praxis precision medicines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Praxis Precision Medicines to Present at Upcoming December Investor Conferences
December 3, 2024
·
2 min read
Press Releases
Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome
December 18, 2024
·
6 min read
Genetown
Praxis Precision Medicines to Participate in Upcoming Investor Conferences - May 17, 2024
Praxis Precision Medicines, Inc. today announced that management will be participating in three upcoming conferences.
May 17, 2024
·
2 min read
Press Releases
Praxis Precision Medicines to Participate in Three Upcoming November 2024 Investor Conferences
November 7, 2024
·
2 min read
Genetown
Praxis Precision Medicines to Participate in Upcoming April Conferences
Praxis Precision Medicines, Inc. today announced that management will take part in upcoming conferences in April.
April 5, 2024
·
1 min read
Press Releases
Praxis Precision Medicines to Showcase Updates from Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting
November 26, 2024
·
6 min read
Press Releases
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results
November 6, 2024
·
14 min read
Press Releases
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
September 5, 2024
·
1 min read
Genetown
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024
Praxis Precision Medicines, Inc. announced that on June 3, 2024, the Compensation Committee of Praxis’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 300 shares of its common stock and restricted stock unit awards covering an aggregate of 225 shares of its common stock to one new non-executive employee under the Praxis Precision Medicines, Inc. 2024 Inducement Plan.
June 4, 2024
·
2 min read
Business
Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024
Praxis Precision Medicines, Inc. announced that it will report financial results for the first quarter 2024 on Monday, May 13, 2024, before the U.S. financial markets open.
May 10, 2024
·
1 min read
1 of 24,807
Next
